Wednesday, Jan 28, 1998

Vice President Gore To Visit Genentech

America's investment in Research and Development to be subject of forum led by Vice President Gore at Genentech

South San Francisco, Calif. -- January 28, 1998 --

Genentech, Inc. (NYSE: GNE) today announced the scheduled visit of Vice President Gore to the company's South San Francisco campus at approximately 1:30 p.m. PST, Thursday, January 29, 1998. During his visit, the Vice President is scheduled to make an important announcement, tour a protein manufacturing plant, and lead a discussion to address the implications of the Administration's support of research and innovation in government, academia, and in the private sector.

Arthur D. Levinson, Ph.D., president and chief executive officer of Genentech, will host the Vice President during his visit. During the Round Table Forum, Vice President Gore will be joined by several leading commentators from America's research and development community, as well as selected scientists and employees of Genentech.

Scheduled guests include: J. Michael Bishop, M.D., director, Hooper Foundation; Brook Byers, partner, Kleiner Perkins Caufield & Byers; John Hennessy, dean, School of Engineering, Stanford University; Dexster Smith, president, Pangea Systems, Inc.

Genentech, Inc. is a leading biotechnology company that discovers, develops, manufactures, and markets human pharmaceuticals for significant unmet medical needs. Eleven of the currently marketed biotechnology products stem from Genentech science. Genentech markets or promotes eight biotechnology products in the United States. The company has headquarters in South San Francisco, California, and is traded on the New York Stock Exchange and Pacific Exchange under the symbol GNE.

# # #